Successful treatment with bortezomib for refractory fever associated with myelodysplastic syndrome with underlying lymphoplasmacytic lymphoma

We report a case of fever of unknown origin in a patient with MDS associated with IgM‐MGUS. The patient was positive for MYD88 mutation, and chemotherapy for LPL/WM improved the fever. Analysis of MYD88 and the effect of chemotherapy on LPL/WM finally revealed the latent LPL/WM in this case.

Detalles Bibliográficos
Autores principales: Motomura, Yotaro, Umezawa, Yoshihiro, Arimatsu, Tomoyuki, Okada, Keigo, Miura, Osamu, Kumagai, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826126/
https://www.ncbi.nlm.nih.gov/pubmed/35154721
http://dx.doi.org/10.1002/ccr3.5372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826126/
https://www.ncbi.nlm.nih.gov/pubmed/35154721
http://dx.doi.org/10.1002/ccr3.5372

Ejemplares similares